What is JNJ's current stock price?

As of now, JNJ is trading at $244.55, with a daily change of +1.53%.

What are the risks associated with JNJ stock?

JNJ has Low, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

JNJ Stock Analysis & IQ Rating | Johnson & Johnson

JNJ

Johnson & Johnson

$244.55

+$3.69 | +1.53%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$246.35

MKT CAP

$589.19B

52W Low

$141.5

VOL

$10.22M

P/E Ratio

22.16

AVG VOL

$8.90M

RSI

85.37

TREND

Uptrend

JNJ Stock IQ

Login to see Johnson & Johnson (JNJ) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

JNJ Target Price

Login to display

Strengths

JNJ Rewards

Earnings are forecast to grow

JNJ Rewards

Outperform the market

JNJ Rewards

Trading below its fair value

JNJ Rewards

Investors confidence is positive

JNJ Price Performance

$219.57 (+11.38%)

$199.58 (+22.53%)

$176.19 (+38.80%)

$165.02 (+48.19%)

1year

6month

3month

1month

JNJ Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

JNJ Analysts Opinion

JNJ Analysts opinion is positive and also has improved from the past 3 months

JNJ Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

85%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

40%

100%

JNJ Street Sentiment

JNJ Street Sentiment is extremely bullish and have positive views on the near-term outlook

JNJ Risk Level

JNJ has Low risk level

Low

LOW

HIGH

JNJ Performance Sentiment

Sentiments overview associated with events and the stock performance

85%

13%

Positive

Negative

84 out of 99
events present

13 out of 99
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$240.86

Resistance
Price

$213.68

Current Price Range

$240.86

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

83%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

5

1

0

Date

Action

Rating

Firm

Feb 02, 2026

Upgrade

Overweight

Morgan Stanley

Jan 28, 2026

Upgrade

Overweight

Morgan Stanley

Dec 17, 2025

Price Target Raised

Neutral

BofA

Dec 12, 2025

Reiterate

Buy

Citigroup

Dec 12, 2025

Reiterate

Outperform

RBC

JNJ Latest Analysis +

NIH Stops Johnson & Johnsons Blood Thinner Drug Arm In Stroke Trial After Safety Review. The National Institutes of Health (NIH) on Tuesday discontinued the low-dose .The primary goal of the is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke intracerebral hemorrhage or vascular death.The move follows an independent safety review that identified increased safety events and evidence that

Wed Feb 11, 2026

$240.86 | +1.07%

Activity

Potential

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now. Dividends are one of the best benefits to being a shareholder but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Lets find out.

Mon Feb 9, 2026

$238.64 | -0.62%

Potential

Noteworthy ETF Outflows: IWD JPM XOM JNJ. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $583.9 million dollar outflow -- thats a 0.8% decrease week over

Mon Feb 9, 2026

$238.64 | -0.62%

Potential

RBC Sees Johnson & Johnson (JNJ) Well Positioned to Manage Legal Overhang. Johnson &. Johnson (NYSE:JNJ) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. On February 3 RBC Capital raised its price target on Johnson &. Johnson (NYSE:JNJ) to $255 from $240 and reiterated an Outperform rating. The firm said the company is unlikely to reverse the core implications of the Daubert [….]

Thu Feb 5, 2026

$237.79 | +1.42%

Activity

Potential

J&J Snack Foods (JJSF) Loses 11% in 4 Weeks Heres Why a Trend Reversal May be Around the Corner. The heavy selling pressure might have exhausted for J&J Snack Foods (JJSF) as it is technically in oversold territory now. In addition to this technical measure strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Wed Feb 4, 2026

$234.47 | +0.59%

Momentum

Johnson & Johnsons Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?. Key PointsJohnson & Johnsons growth rate improved this past year and that trend is likely to continue.

Wed Feb 4, 2026

$234.47 | +0.59%

Potential

Relative Strength Alert For J&J Snack Foods . The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics &mdash. strong fundamentals and a valuation that looks inexpensive.

Tue Feb 3, 2026

$233.10 | +1.02%

Earnings

Potential

J&J Snack Foods falls after the bakery business disappointed in FQ1.

Tue Feb 3, 2026

$233.10 | +1.02%

Activity

Momentum

Morgan Stanley Upgrades Johnson & Johnson to Overweight Increases PT to $262. Johnson &. Johnson (NYSE:JNJ) is one of the 10 Hottest Stocks to Buy in 2026. On January 28 TheFly reported that Morgan Stanley upgraded Johnson &. Johnson (NYSE:JNJ) from Equal Weight to Overweight increasing the price target from $200 to $262. Terence Flynn from Morgan Stanley remains ish on the company as he expects higher [….]

Mon Feb 2, 2026

$230.75 | +1.54%

Rating

Johnson & Johnson: Fraud Claim Dismissal Today Is Not A Sign Talc Litigation Is Over.

Fri Jan 30, 2026

$227.25 | +0.01%

Activity

Runners Also Watch

Close Price

Change

NBTX

Nanobiotix S.A. American

24.49

+1.53%

BLTE

Belite Bio Inc

174.61

-0.26%

ANNX

Annexon

5.19

-0.95%

SNDX

Syndax Pharmaceutica

21.14

-2.63%

REGN

Regeneron Pharma

783.65

+0.60%

FAQ About JNJ Stock Insights

What is JNJ current stock price?

What are JNJ stock strengths?

What is JNJ Risk Level?

What is JNJ market cap and volume?

What is JNJ current Stock IQ?

Should I buy JNJ stock right now?

Is JNJ a Strong Buy right now?

What does a 'Strong Buy' rating mean for JNJ?

What does a 'Strong Sell' rating mean for JNJ?

What factors influence JNJ's Stock IQ?

Explore our JNJ Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored JNJ Stock Strategies
Effective Risk Management

FIND US ON

Receive our JNJ Daily Alerts

Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

JNJ

Johnson & Johnson

Set Alerts

Current Price

$244.55

+$3.69 | +1.53%

52W High

$246.35

MKT CAP

$589.19B

52W Low

$141.5

VOL

$10.22M

P/E Ratio

22.16

AVG VOL

$8.90M

RSI

85.37

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Runners Also Watch

Symbol

Close

Change

NBTX

Nanobiotix S.A. American

24.49

+1.53%

BLTE

Belite Bio Inc

174.61

-0.26%

ANNX

Annexon

5.19

-0.95%

SNDX

Syndax Pharmaceutica

21.14

-2.63%

REGN

Regeneron Pharma

783.65

+0.60%

JNJ Price Performance

$219.57 (+11.38%)

$199.58 (+22.53%)

$176.19 (+38.80%)

$165.02 (+48.19%)

1year

6month

3month

1month

JNJ Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

JNJ Analysts Opinion

JNJ Analysts opinion is positive and also has improved from the past 3 months

JNJ Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

85%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

40%

100%

JNJ Street Sentiment

JNJ Street Sentiment is extremely bullish and have positive views on the near-term outlook

JNJ Risk Level

JNJ has Low risk level

Low

LOW

HIGH

JNJ Performance Sentiment

Sentiments overview associated with events and the stock performance.

85%

13%

Positive

Negative

84 out of 99
events present

13 out of 99
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$240.86

Resistance
Price

$213.68

Current Price Range

$240.86

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

83%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

5

1

0

Date

Action

Rating

Firm

Feb 02, 2026

Upgrade

Overweight

Morgan Stanley

Jan 28, 2026

Upgrade

Overweight

Morgan Stanley

Dec 17, 2025

Price Target Raised

Neutral

BofA

Dec 12, 2025

Reiterate

Buy

Citigroup

Dec 12, 2025

Reiterate

Outperform

RBC

JNJ Stock IQ

Login to unlock Johnson & Johnson (JNJ) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

JNJ Rewards

Earnings are forecast to grow

JNJ Rewards

Outperform the market

JNJ Rewards

Trading below its fair value

JNJ Rewards

Investors confidence is positive

JNJ Latest Analysis

NIH Stops Johnson & Johnsons Blood Thinner Drug Arm In Stroke Trial After Safety Review. The National Institutes of Health (NIH) on Tuesday discontinued the low-dose .The primary goal of the is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke intracerebral hemorrhage or vascular death.The move follows an independent safety review that identified increased safety events and evidence that

Wed Feb 11, 2026

$240.86 | +1.07%

Activity

Potential

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now. Dividends are one of the best benefits to being a shareholder but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Lets find out.

Mon Feb 9, 2026

$238.64 | -0.62%

Potential

Noteworthy ETF Outflows: IWD JPM XOM JNJ. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $583.9 million dollar outflow -- thats a 0.8% decrease week over

Mon Feb 9, 2026

$238.64 | -0.62%

Potential

RBC Sees Johnson & Johnson (JNJ) Well Positioned to Manage Legal Overhang. Johnson &. Johnson (NYSE:JNJ) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. On February 3 RBC Capital raised its price target on Johnson &. Johnson (NYSE:JNJ) to $255 from $240 and reiterated an Outperform rating. The firm said the company is unlikely to reverse the core implications of the Daubert [….]

Thu Feb 5, 2026

$237.79 | +1.42%

Activity

Potential

J&J Snack Foods (JJSF) Loses 11% in 4 Weeks Heres Why a Trend Reversal May be Around the Corner. The heavy selling pressure might have exhausted for J&J Snack Foods (JJSF) as it is technically in oversold territory now. In addition to this technical measure strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Wed Feb 4, 2026

$234.47 | +0.59%

Momentum

Johnson & Johnsons Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?. Key PointsJohnson & Johnsons growth rate improved this past year and that trend is likely to continue.

Wed Feb 4, 2026

$234.47 | +0.59%

Potential

Relative Strength Alert For J&J Snack Foods . The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics &mdash. strong fundamentals and a valuation that looks inexpensive.

Tue Feb 3, 2026

$233.10 | +1.02%

Earnings

Potential

Discover JNJ Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of JNJ. We're here to help you make informed investment decisions today.

FIND US ON

Receive our JNJ Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

JNJ Stock trends

JNJ Stock performance

JNJ Stock analysis

JNJ investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing JNJ

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing JNJ

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

JNJ Stock Analysis & IQ Rating | Johnson & Johnson

JNJ Stock IQ

JNJ Target Price

JNJ Analysts Opinion

JNJ Street Sentiment

JNJ Risk Level

JNJ Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our JNJ Stock insights

Receive our JNJ Daily Alerts

JNJ Street Sentiment

JNJ Risk Level

Key Price Levels

Latest Analyst Actions

Discover JNJ Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of JNJ. We're here to help you make informed investment decisions today.

Receive our JNJ Daily Alerts

JNJ Alerts